Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DEXAMETHASONE | 0.5MG | TABLET | Resolved | 2019-12-05 | 2020-09-21 | 100271 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2019-12-05 | 2020-02-25 | 100278 |
APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-12-05 | 2019-12-23 | 100314 |
APO-QUETIAPINE | 100MG | TABLET | Resolved | 2019-12-05 | 2019-12-09 | 100317 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2019-12-12 | 2020-01-15 | 101082 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2019-12-12 | 2020-01-22 | 101088 |
APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-12-12 | 2020-01-07 | 101094 |
APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2019-12-12 | 2020-03-27 | 101097 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-12-18 | 2020-03-09 | 101517 |
APO-BACLOFEN | 10MG | TABLET | Resolved | 2020-01-08 | 2020-02-10 | 102531 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2020-01-08 | 2020-02-10 | 102572 |
APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102666 |
APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102671 |
APO-AMOXI CLAV | 250MG 125MG | TABLET | Resolved | 2020-01-15 | 2020-02-19 | 103357 |
APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2020-01-15 | 2020-01-31 | 103362 |
APO-RILUZOLE | 50MG | TABLET | Resolved | 2020-01-15 | 2022-09-23 | 103385 |
APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2020-01-15 | 2020-04-09 | 103391 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-01-22 | 2020-02-21 | 103914 |
APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2020-01-22 | 2020-03-27 | 103920 |
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2020-01-22 | 2020-03-09 | 103923 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |